MaxCyte Inc
LSE:MXCT
MaxCyte Inc
Selling, General & Administrative
MaxCyte Inc
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
MaxCyte Inc
LSE:MXCT
|
Selling, General & Administrative
-$57m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Selling, General & Administrative
-$8.4B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
Danaher Corp
NYSE:DHR
|
Selling, General & Administrative
-$13.4B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-10%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Selling, General & Administrative
-$903.8m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-3%
|
|
Agilent Technologies Inc
NYSE:A
|
Selling, General & Administrative
-$1.6B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Selling, General & Administrative
-$2.1B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-9%
|
See Also
What is MaxCyte Inc's Selling, General & Administrative?
Selling, General & Administrative
-57m
USD
Based on the financial report for Dec 31, 2023, MaxCyte Inc's Selling, General & Administrative amounts to -57m USD.
What is MaxCyte Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-37%
Over the last year, the Selling, General & Administrative growth was -28%. The average annual Selling, General & Administrative growth rates for MaxCyte Inc have been -51% over the past three years , -37% over the past five years .